Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy

Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.10279-10280
Hauptverfasser: Reimann, Hannah, Kremer, Anita Natalie, Blumenberg, Viktoria, Schmidt, Katja, Aigner, Michael, Kremer, Andreas, Tenbusch, Matthias, Bruns, Heiko, Harrer, Thomas, Schett, Georg, Mueller, Fabian, Mackensen, Andreas, Subklewe, Marion, Voelkl, Simon
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10280
container_issue Supplement 1
container_start_page 10279
container_title Blood
container_volume 140
creator Reimann, Hannah
Kremer, Anita Natalie
Blumenberg, Viktoria
Schmidt, Katja
Aigner, Michael
Kremer, Andreas
Tenbusch, Matthias
Bruns, Heiko
Harrer, Thomas
Schett, Georg
Mueller, Fabian
Mackensen, Andreas
Subklewe, Marion
Voelkl, Simon
description
doi_str_mv 10.1182/blood-2022-165968
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_165968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122061791</els_id><sourcerecordid>S0006497122061791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1858-735dd0b7ffda29ffe857189e56c795a1ab5ce6b4b3f05332470321aa39b9b2fc3</originalsourceid><addsrcrecordid>eNp9kMtKAzEARYMoWKsf4C4_kJrHZCbBVRkfLRQUrW5DnhiZR0lmhP6909a1q7s6l3sPALcELwgR9M40fe8QxZQiUnJZijMwI5wKhDHF52CGMS5RIStyCa5y_saYFIzyGTDvOmVU9z-Iwk9tbew8WndutN7B2jfN2OgEdefgamz7pBu4btuxi8Mexg6-6iH6bshQh8EnWD8QuaiXb2h7ROH2yye921-Di6Cb7G_-cg4-nh639QptXp7X9XKDLBFcoIpx57CpQnCayhC84BUR0vPSVpJrog23vjSFYQFzxmhRYUaJ1kwaaWiwbA7IqdemPufkg9ql2Oq0VwSrgyR1lKQOktRJ0sTcnxg_DfuJPqlsp0vT-5i8HZTr4z_0L0inbnk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Reimann, Hannah ; Kremer, Anita Natalie ; Blumenberg, Viktoria ; Schmidt, Katja ; Aigner, Michael ; Kremer, Andreas ; Tenbusch, Matthias ; Bruns, Heiko ; Harrer, Thomas ; Schett, Georg ; Mueller, Fabian ; Mackensen, Andreas ; Subklewe, Marion ; Voelkl, Simon</creator><creatorcontrib>Reimann, Hannah ; Kremer, Anita Natalie ; Blumenberg, Viktoria ; Schmidt, Katja ; Aigner, Michael ; Kremer, Andreas ; Tenbusch, Matthias ; Bruns, Heiko ; Harrer, Thomas ; Schett, Georg ; Mueller, Fabian ; Mackensen, Andreas ; Subklewe, Marion ; Voelkl, Simon</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-165968</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.10279-10280</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1858-735dd0b7ffda29ffe857189e56c795a1ab5ce6b4b3f05332470321aa39b9b2fc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Reimann, Hannah</creatorcontrib><creatorcontrib>Kremer, Anita Natalie</creatorcontrib><creatorcontrib>Blumenberg, Viktoria</creatorcontrib><creatorcontrib>Schmidt, Katja</creatorcontrib><creatorcontrib>Aigner, Michael</creatorcontrib><creatorcontrib>Kremer, Andreas</creatorcontrib><creatorcontrib>Tenbusch, Matthias</creatorcontrib><creatorcontrib>Bruns, Heiko</creatorcontrib><creatorcontrib>Harrer, Thomas</creatorcontrib><creatorcontrib>Schett, Georg</creatorcontrib><creatorcontrib>Mueller, Fabian</creatorcontrib><creatorcontrib>Mackensen, Andreas</creatorcontrib><creatorcontrib>Subklewe, Marion</creatorcontrib><creatorcontrib>Voelkl, Simon</creatorcontrib><title>Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKAzEARYMoWKsf4C4_kJrHZCbBVRkfLRQUrW5DnhiZR0lmhP6909a1q7s6l3sPALcELwgR9M40fe8QxZQiUnJZijMwI5wKhDHF52CGMS5RIStyCa5y_saYFIzyGTDvOmVU9z-Iwk9tbew8WndutN7B2jfN2OgEdefgamz7pBu4btuxi8Mexg6-6iH6bshQh8EnWD8QuaiXb2h7ROH2yye921-Di6Cb7G_-cg4-nh639QptXp7X9XKDLBFcoIpx57CpQnCayhC84BUR0vPSVpJrog23vjSFYQFzxmhRYUaJ1kwaaWiwbA7IqdemPufkg9ql2Oq0VwSrgyR1lKQOktRJ0sTcnxg_DfuJPqlsp0vT-5i8HZTr4z_0L0inbnk</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Reimann, Hannah</creator><creator>Kremer, Anita Natalie</creator><creator>Blumenberg, Viktoria</creator><creator>Schmidt, Katja</creator><creator>Aigner, Michael</creator><creator>Kremer, Andreas</creator><creator>Tenbusch, Matthias</creator><creator>Bruns, Heiko</creator><creator>Harrer, Thomas</creator><creator>Schett, Georg</creator><creator>Mueller, Fabian</creator><creator>Mackensen, Andreas</creator><creator>Subklewe, Marion</creator><creator>Voelkl, Simon</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy</title><author>Reimann, Hannah ; Kremer, Anita Natalie ; Blumenberg, Viktoria ; Schmidt, Katja ; Aigner, Michael ; Kremer, Andreas ; Tenbusch, Matthias ; Bruns, Heiko ; Harrer, Thomas ; Schett, Georg ; Mueller, Fabian ; Mackensen, Andreas ; Subklewe, Marion ; Voelkl, Simon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1858-735dd0b7ffda29ffe857189e56c795a1ab5ce6b4b3f05332470321aa39b9b2fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reimann, Hannah</creatorcontrib><creatorcontrib>Kremer, Anita Natalie</creatorcontrib><creatorcontrib>Blumenberg, Viktoria</creatorcontrib><creatorcontrib>Schmidt, Katja</creatorcontrib><creatorcontrib>Aigner, Michael</creatorcontrib><creatorcontrib>Kremer, Andreas</creatorcontrib><creatorcontrib>Tenbusch, Matthias</creatorcontrib><creatorcontrib>Bruns, Heiko</creatorcontrib><creatorcontrib>Harrer, Thomas</creatorcontrib><creatorcontrib>Schett, Georg</creatorcontrib><creatorcontrib>Mueller, Fabian</creatorcontrib><creatorcontrib>Mackensen, Andreas</creatorcontrib><creatorcontrib>Subklewe, Marion</creatorcontrib><creatorcontrib>Voelkl, Simon</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reimann, Hannah</au><au>Kremer, Anita Natalie</au><au>Blumenberg, Viktoria</au><au>Schmidt, Katja</au><au>Aigner, Michael</au><au>Kremer, Andreas</au><au>Tenbusch, Matthias</au><au>Bruns, Heiko</au><au>Harrer, Thomas</au><au>Schett, Georg</au><au>Mueller, Fabian</au><au>Mackensen, Andreas</au><au>Subklewe, Marion</au><au>Voelkl, Simon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>10279</spage><epage>10280</epage><pages>10279-10280</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-165968</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.10279-10280
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_165968
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sars-Cov-2%20Vaccine-Induced%20Cellular%20and%20Humoral%20Immunity%20in%20Patients%20after%20CD19.CAR-T%20Cell%20Therapy&rft.jtitle=Blood&rft.au=Reimann,%20Hannah&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=10279&rft.epage=10280&rft.pages=10279-10280&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-165968&rft_dat=%3Celsevier_cross%3ES0006497122061791%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122061791&rfr_iscdi=true